Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome

Cancer Genetics and Cytogenetics

Volumn 149, Issue 2, 2004, Pages 169-172

  Au, Wing Y ^a   Fung, Alvin T ^a   Ma, Edmond S ^a   Liang, Raymond H ^a   Kwong, Yok L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; BLOOD CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FMS RELATED TYROSINE KINASE 3 GENE; GENE; GENE DUPLICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE DUPLICATION; GENE FREQUENCY; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 1442299812     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.07.007     Document Type: Article

References (13)

1. Gilliland D.G., Griffin J.D. The roles of FLT3 in hematopoiesis and leukemia. Blood. 100:2002;1532-1542.
2. Thiede C., Steudel C., Mohr B., Schaich M., Schakel U., Platzbecker U., Wermke M., Bornhauser M., Ritter M., Neubauer A., Ehninger G., Illmer T. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 99:2002;4326-4335.
3. Horiike S., Yokota S., Nakao M., Iwai T., Sasai Y., Kaneko H., Taniwaki M., Kashima K., Fujii H., Abe T., Misawa S. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia. 11:1997;1442-1446.
4. Pedersen-Bjergaard J., Andersen M.K., Christiansen D.H., Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood. 99:2002;1909-1912.
5. Mitelman F. An international system for human cytogenetic nomenclature (1995). 1995;S. Karger, Basel.
6. Kottaridis P.D., Gale R.E., Langabeer S.E., Frew M.E., Bowen D.T., Linch D.C. Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood. 100:2002;2393-2398.
7. Christiansen D.H., Pedersen-Bjergaard J. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy. Leukemia. 15:2001;1848-1851.
8. *2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood. 101:2003;2770-2774.
9. Christiansen D.H., Andersen M.K., Pedersen-Bjergaard J. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol. 19:2001;1405-1413.
10. Stirewalt D.L., Kopecky K.J., Meshinchi S., Appelbaum F.R., Slovak M.L., Willman C.L., Radich J.P. FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood. 97:2001;3589-3595.
11. Au W.Y., Fung A., Man C., Ma S.K., Wan T.S., Liang R., Kwong Y.L. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Br J Haematol. 120:2003;1062-1065.
12. Noguera N.I., Breccia M., Divona M., Diverio D., Costa V., De Santis S., Avvisati G., Pinazzi M.B., Petti C., Mandelli F., Lo Coco F. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia. 16:2002;2185-2189.
13. Kelly L.M., Kutok J.L., Williams I.R., Boulton C.L., Amaral S.M., Curley D.P., Ley T.J., Gilliland D.G. PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A. 99:2002;8283-8288.